Irene Nunes
Merck & Co., Inc., Rahway, NJ, USA (United States) · 29 works · 3,628 citations · h-index 17
Top works
- An Assay for Transforming Growth Factor-β Using Cells Transfected with a Plasminogen Activator Inhibitor-1 Promoter-Luciferase Construct
- Latent transforming growth factor-β: Structural features and mechanisms of activation
- Latent Transforming Growth Factor-β Binding Protein Domains Involved in Activation and Transglutaminase-dependent Cross-Linking of Latent Transforming Growth Factor-β
- Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation
- Characterization of latent TGF-β activation by murine peritoneal macrophages
- TGF‐β Latency: Biological Significance and Mechanisms of Activation
- Pitx3 is required for development of substantia nigra dopaminergic neurons
- Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type mice: cellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals.
- Structure and activation of the large latent transforming growth factor-beta complex.
- The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?
- Host-Defense Mechanism of the Ocular Surfaces
- GRIFIN, a Novel Lens-specific Protein Related to the Galectin Family
- Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles.
- Effects of endogenously activated transforming growth factor-beta on growth and differentiation of retinoic acid-treated HL-60 cells.
- Plasminogen/Plasminogen Activator and Growth Factor Activation
- Structure and activation of the large latent transforming growth factor-Beta complex.
- Transporters affecting biochemical test results: Creatinine‐drug interactions
- C-Abl Is Required for the Development of Hyperoxia-Induced Retinopathy
- Segmental Bioimpedance for Measuring Amlodipine-Induced Pedal Edema: A Placebo-Controlled Study
- Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury